LCN2 and breast carcinoma: Given that obesity at diagnosis of breast cancer has been associated with an increased risk of recurrence and death [43,44], it is possible that the impact of lipocalin-2 level and/or combined score on DFS could only be demonstrated in the lower BMI group, with these markers being independent prognostic factors of breast cancer.